# Reducing the Duration of Untreated Psychosis in the United States: The Impact of Screening and Systematic Communication

> **NCT05509998** · NA · ENROLLING_BY_INVITATION · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 912 (estimated)

## Conditions studied

- First Episode Psychosis (FEP)
- Clinical High Risk for Psychosis (CHR)

## Interventions

- **BEHAVIORAL:** Screening Method (SM)
- **BEHAVIORAL:** Screening and Communication Method (SCM)

## Key facts

- **NCT ID:** NCT05509998
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-05-01
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-04-30
- **Target enrollment:** 912 (ESTIMATED)
- **Last updated:** 2025-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05509998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05509998, "Reducing the Duration of Untreated Psychosis in the United States: The Impact of Screening and Systematic Communication". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05509998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*